Genesis Private Wealth LLC acquired a new position in shares of Teleflex Incorporated (NYSE:TFX – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,185 shares of the medical technology company’s stock, valued at approximately $211,000.
Several other hedge funds also recently modified their holdings of the company. Oak Thistle LLC increased its holdings in Teleflex by 243.9% during the 4th quarter. Oak Thistle LLC now owns 10,695 shares of the medical technology company’s stock valued at $1,903,000 after purchasing an additional 7,585 shares in the last quarter. Mendota Financial Group LLC acquired a new stake in shares of Teleflex in the fourth quarter valued at $124,000. Bridge Creek Capital Management LLC raised its holdings in shares of Teleflex by 1.7% in the fourth quarter. Bridge Creek Capital Management LLC now owns 16,730 shares of the medical technology company’s stock valued at $2,978,000 after buying an additional 285 shares during the last quarter. Czech National Bank lifted its position in Teleflex by 4.9% during the 4th quarter. Czech National Bank now owns 10,070 shares of the medical technology company’s stock worth $1,792,000 after buying an additional 472 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its position in Teleflex by 4.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 3,305 shares of the medical technology company’s stock worth $588,000 after buying an additional 128 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on TFX shares. Royal Bank of Canada dropped their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Mizuho dropped their price objective on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Finally, Truist Financial decreased their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, Teleflex presently has an average rating of “Moderate Buy” and a consensus price target of $252.50.
Teleflex Stock Down 1.1 %
NYSE:TFX opened at $180.52 on Thursday. The stock’s fifty day simple moving average is $183.55 and its 200-day simple moving average is $215.06. The firm has a market capitalization of $8.38 billion, a P/E ratio of 35.89, a P/E/G ratio of 1.71 and a beta of 1.16. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 12-month low of $171.69 and a 12-month high of $256.85.
Teleflex (NYSE:TFX – Get Free Report) last posted its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.38 by $0.11. The company had revenue of $764.40 million during the quarter, compared to analyst estimates of $768.68 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company’s revenue for the quarter was up 2.4% compared to the same quarter last year. During the same period in the previous year, the company earned $3.64 EPS. Equities research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.
Teleflex Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, December 16th. Shareholders of record on Friday, November 15th were issued a $0.34 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.36 annualized dividend and a yield of 0.75%. Teleflex’s dividend payout ratio (DPR) is presently 27.04%.
About Teleflex
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
See Also
- Five stocks we like better than Teleflex
- How to Use the MarketBeat Excel Dividend Calculator
- Oracle Announces Game-Changing News for the AI Industry
- When to Sell a Stock for Profit or Loss
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Election Stocks: How Elections Affect the Stock Market
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.